Recursion is advancing REC-617, a promising reversible, non-covalent CDK7 inhibitor, showing potential in treating advanced solid tumors with positive interim phase 1 data. Read more here.

Adyen N.V.'s stock rebounds with strong H2 2024 results and growth in North America. Click here to find out why ADYEY is a ...

Good afternoon, and welcome to the Coinbase fourth quarter and full year 2024 earnings call. Joining me on today's cal ...

The dual degree program in Mathematics and Industrial Engineering at Gallaudet University and Rochester Institute of ...

Operator Good morning, and welcome to S&P Global's fourth quarter and full year 2024 earnings conference call. I'd like to ...

NEW YORK--(BUSINESS WIRE)--Derivative Path, a leading provider of cloud-based derivatives and risk management solutions, is pleased to announce the appointment of Rob Showers as Chief Revenue Officer ...

Sumit Poddar, from Tikona Capital, discusses the market correction and predicts a better economic outlook in the upcoming ...

Stem-cell differentiation is the process by which a more specialised cell is formed from a stem cell, leading to loss of some of the stem cell's developmental potential. Stem-cell differentiation ...

So, we have enough investment themes to look at within India and I do not think that from that perspective tariffs is going ...

OpenAI’s first Super Bowl commercial served as a blinking prompt for the AI juggernaut to launch its first foray into mass marketing.

Mulberry Market was valued at USD 38.4 Bn in 2023. It is expected to reach USD 59.0 Bn by 2033, with a CAGR of 4.5% < ...

Megakaryocytes form a three-dimensional (3D) cage composed of laminin and collagen IV connected to the basement membrane surrounding them. This microarchitecture stabilizes megakaryocytes within their ...